Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

ITP - Immune Thrombocytopenia

Interventions

DRUG

eltrombopag and romiplastim

"Group I: eltrombopag and romiplastim~Group II : recived corticosteroid."

All Listed Sponsors

collaborator

Association for Training, Education, and Research in Hematology, Immunology, and Transplantation

OTHER

lead

Assiut University

OTHER

NCT06137105 - Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura | Biotech Hunter | Biotech Hunter